Neurology News

Placebo/Nocebo and the Brain [World Neurology 39:1 Editor's Choice]

25 Mar 2024

Placebo and recently the term nocebo are often used in situations where uncertain effects, possibly the effect of the mind works, and have been often disregarded as scientifical activities. All of us working with patients are implicitly using the concept of placebo, and sometimes the negative prediction, the nocebo.

24 March is World Tuberculosis Day

22 Mar 2024

The date marks the day in 1882 when Dr. Robert Koch announced that he had discovered the bacterium that causes TB, which opened the way towards diagnosing and curing this disease.

Journal of the Neurological Sciences issue 458 now available

15 Mar 2024

Vol. 458, March 2024 now available

Over 1 in 3 people affected by neurological conditions, the leading cause of illness and disability worldwide

14 Mar 2024

Neurological conditions now leading cause of ill health and disability globally, affecting 3.4 billion people worldwide.

Hemorrhagic transformation after endovascular therapy - Asymptomatic or agnostic? [JNS457 Editor's Choice]

13 Mar 2024

The quandary persists, how can “asymptomatic” HT be linked with a serious adverse event and worse clinical outcomes, whether due to spontaneous recanalization, IVT or EVT? Perhaps, the stroke community is agnostic to ever knowing or realizing the actual causal relationship of HT with respect to individual patient-related factors or specific treatments, including combinations with IVT and EVT. It is also quite arbitrary to designate certain cases of HT as “asymptomatic” when we truly cannot disprove a link with symptoms or long-term clinical outcomes. In short, it is increasingly clear that our current definitions of HT require an update in 2024. 

“One Brain, One Health” The Italian Strategy for Brain Health 2024-2031

10 Mar 2024

While some forms of Parkinson’s disease are caused by genetics, others have environmental factors, and patients can show a wide range of symptoms of varying severity. In a paper published in The Lancet Neurology, a group of scientists argue that this complexity demands a new way of classifying the disease for research purposes, one based not on clinical diagnosis but biology. The authors have called their biological model “SynNeurGe”.

eNeurologicalSci (eNS) March 2024 issue

6 Mar 2024

The WFN March 2024 issue of the OPEN ACCESS journal eNeurologicalSci Vol. 34 is now available online.

The Online Mendelian Inheritance in Man (OMIM) Database [World Neurology 39:1 Editor's Choice]

4 Mar 2024

For over 55 years, OMIM has chronicled the collected knowledge of the field of medical genetics and remains one of the primary repositories of curated information on both genetic disorders (phenotypes) and genes and the relationships between them. 

Effect of asymptomatic intracranial hemorrhage after mechanical thrombectomy on clinical outcome [JNS457 Editor's Choice]

24 Feb 2024

Whether asymptomatic intracranial hemorrhage (ICH) affects the clinical outcomes in patients with acute large vessel occlusion treated with mechanical thrombectomy (MT) remains unclear. This study aimed to address this uncertainty.

Journal of the Neurological Sciences issue 457 now available

14 Feb 2024

Vol. 457, February 2024 now available

1